Late Breaking Abstract - Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study
Year: 2021
Type: conference-abstract
Source: European Respiratory Journal
Institutions: Harefield Hospital, University of Cambridge, Wellcome/MRC Institute of Metabolic Science, NIHR Cambridge Biomedical Research Centre, Queen's University Belfast, University of California, Los Angeles, Amsterdam University Medical Centers, University of Amsterdam, University of Nottingham, Nottingham Biomedical Research Centre, King's College London, Asthma UK, Observational & Pragmatic Research Institute, University of Michigan, Michigan Medicine, AstraZeneca (United States), AstraZeneca (United Kingdom), AstraZeneca (Spain)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3215420731
